Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla ACADIA Pharmaceuticals Inc.
| Okres |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1,064.88 |
1,180.33 |
1,318.08 |
1,463.59 |
1,632.54 |
| Przychód Δ r/r |
0.00% |
10.84% |
11.67% |
11.04% |
11.54% |
| Przychód (min) |
1,034.46 |
1,120.20 |
1,317.62 |
1,416.95 |
1,580.52 |
| Przychód (max) |
1,105.45 |
1,327.18 |
1,318.54 |
1,557.62 |
1,737.42 |
| EBITDA (średnia) |
-300.52 |
-333.10 |
-371.97 |
-413.04 |
-460.72 |
| EBIT (średnia) |
-309.40 |
-342.94 |
-382.96 |
-425.24 |
-474.33 |
| EBIT % |
-29.05% |
-29.05% |
-29.05% |
-29.05% |
-29.05% |
| Zysk netto (średni) |
86.59 |
156.53 |
282.46 |
345.80 |
422.21 |
| Zysk netto % |
8.13% |
13.26% |
21.43% |
23.63% |
25.86% |
| EPS (średnia) |
0.52 |
0.85 |
1.56 |
2.08 |
2.54 |
| Liczba analityków (Przychody) |
13 |
19 |
15 |
6 |
11 |
| Liczba analityków (EPS) |
12 |
15 |
13 |
9 |
11 |
| symbol |
ACAD |
ACAD |
ACAD |
ACAD |
ACAD |